No signal was created. All models' risk/reward ratios were below the 1.5:1 minimum.
Best R:R was 1.34:1 (minimum 1.5:1)
All three models condemn the company's extreme overvaluation (123x P/S) and catastrophic execution, evidenced by a -433% EPS miss and the four-year delay of the flagship Romania VOYGR project to 2034. Technical analysis across all models confirms a decisive bearish trend with the price below key SMAs, an RSI of 37.58, and a negative MACD of -1.29. Unique risks include the global energy supply shock favoring traditional fuels over speculative nuclear, and a specific analyst price target of $11.42 suggesting further downside below current support levels.
All three models emphasize NuScale's unique regulatory moat as the only NRC-certified SMR designer, positioning it to capture surging AI data center demand through its 6GW TVA agreement and €200M in EU backing. Two models highlight that with the stock down 78-92% from its all-time high and trading near its $11.08 support, the 25.7% short interest could trigger a violent short squeeze on any positive DOE loan catalyst. Unique strengths include the ENTRA1 partnership for commercialization and the potential for a contrarian reversal given high institutional ownership (45%).
SMR is a fundamentally broken story with massive execution failures. The Romania RoPower project was just delayed 4 years (from 2030 to 2034) , causing a 26.5% plunge in February. The company continues to hemorrhage money with EPS of - $2.17 and the most recent earnings showed a -433% surprise (actual - $0.80 vs estimate - $0.15) . At a price-to-sales of 123x with only $31M in revenue, the valuation is absurd for a company with no near-term commercialization path. Analyst price target of $11.42 implies further downside. Technicals are strongly bearish with RSI at 37.58, MACD deeply negative at -1.29, and price below both SMAs. The 52-week low of $11.08 is the last support before potential capitulation.
SMR is a fundamentally broken story with massive execution failures. The Romania RoPower project was just delayed 4 years (from 2030 to 2034) , causing a 26.5% plunge in February. The company continues to hemorrhage money with EPS of - $2.17 and the most recent earnings showed a -433% surprise (actual - $0.80 vs estimate - $0.15) . At a price-to-sales of 123x with only $31M in revenue, the valuation is absurd for a company with no near-term commercialization path. Analyst price target of $11.42 implies further downside. Technicals are strongly bearish with RSI at 37.58, MACD deeply negative at -1.29, and price below both SMAs. The 52-week low of $11.08 is the last support before potential capitulation.
SMR is trading just 10% above its 52-week low of $11.08 after a brutal 78% decline from highs, creating a potential mean-reversion opportunity at deeply oversold levels. The RSI at 37.58 is rising, suggesting momentum is shifting, while the price sits at a high-volume node ($12.43) which historically acts as strong support. The EU's March 10th announcement of a €200 million guarantee and strategy to deploy SMRs by early 2030s provides a significant tailwind for the entire small modular reactor sector. NuScale remains the ONLY SMR company with U.S. Nuclear Regulatory Commission design certification, giving it a first-mover advantage as energy security concerns intensify amid the Strait of Hormuz crisis. The 6-gigawatt TVA project represents massive long-term revenue potential, and institutional ownership at 45% suggests smart money is positioned for the nuclear renaissance.
Thesis Competition: BEAR case won (58% vs 55%).
SMR is down 78.7% from its 52-week high of $57.42, trading at an absurd 123x price-to-sales ratio with negative earnings (- $2.17 EPS) and a business generating only $31M in revenue against a $3.8B market cap. Recent earnings have been catastrophic disasters - Q4 2025 missed by 1, 221% (- $1.85 vs - $0.14 estimate) and Feb 2026 missed by 433% (- $0.80 vs - $0.15 estimate) , demonstrating zero execution capability. The flagship Romania VOYGR project has been delayed by FOUR YEARS to 2034, revealing that commercialization timelines are pure fantasy. Technical structure is decisively bearish with RSI at 37.58, price below both SMAs, strong bearish signal, and resistance at $13.48 capping any relief rallies. The company burns cash with no path to profitability, 25.7% short interest signals institutional skepticism, and the global energy supply shock from Hormuz favors traditional energy over speculative pre-revenue nuclear plays.
SMR is down 78.7% from its 52-week high of $57.42, trading at an absurd 123x price-to-sales ratio with negative earnings (- $2.17 EPS) and a business generating only $31M in revenue against a $3.8B market cap. Recent earnings have been catastrophic disasters - Q4 2025 missed by 1, 221% (- $1.85 vs - $0.14 estimate) and Feb 2026 missed by 433% (- $0.80 vs - $0.15 estimate) , demonstrating zero execution capability. The flagship Romania VOYGR project has been delayed by FOUR YEARS to 2034, revealing that commercialization timelines are pure fantasy. Technical structure is decisively bearish with RSI at 37.58, price below both SMAs, strong bearish signal, and resistance at $13.48 capping any relief rallies. The company burns cash with no path to profitability, 25.7% short interest signals institutional skepticism, and the global energy supply shock from Hormuz favors traditional energy over speculative pre-revenue nuclear plays.
SMR is trading just 10% above its 52-week low of $11.08 with deeply oversold RSI at 37.58 (rising momentum) near critical high-volume support at the POC of $12.92. The stock sits at an inflection point with massive fundamental catalysts: EU just unveiled a €200M guarantee strategy (March 10, 2026) to bring SMRs online by early 2030s, validating Nu Scale's first-mover advantage as the ONLY NRC-certified SMR design. The historic 6GW TVA partnership positions NuScale to capture the exploding data center and AI power demand that requires reliable carbon-free baseload. At a $3.8B market cap with zero debt (D/E = 0) and 4.3x current ratio, the balance sheet is fortress-strong to weather execution risks. Price/sales of 123x reflects pre-revenue valuation compression—any commercial traction triggers massive re-rating potential. The technical setup shows price consolidating at value area support ( $11.95- $17.29) after a brutal 78% drawdown from highs, creating asymmetric risk/reward for patient capital betting on the nuclear renaissance theme.
Thesis Competition: BEAR case won (68% vs 62%).
Technical breakdown below SMA50 (12.35) confirms distribution phase. Negative EPS surprises (-433% last quarter) and 123x P/S ratio suggest extreme overvaluation. Volume profile shows minimal support until $11.95 with POC resistance at $12.92.
Technical breakdown below SMA50 (12.35) confirms distribution phase. Negative EPS surprises (-433% last quarter) and 123x P/S ratio suggest extreme overvaluation. Volume profile shows minimal support until $11.95 with POC resistance at $12.92.
NuScale holds first-mover advantage with NRC-certified SMR tech, positioned to benefit from Europe's €5B+ nuclear push. Oversold RSI (37.58) near $11.22 support provides technical rebound potential. Clean balance sheet (zero debt, 4.3x current ratio) enables survival through development phase.
Thesis Competition: BEAR case won (68% vs 55%).